共 19 条
Biodistribution of TNF-α-coated gold nanoparticles in an in vivo model system
被引:101
作者:
Goel, Raghav
[1
]
Shah, Neha
[1
]
Visaria, Rachana
[2
]
Paciotti, Giulio F.
[3
]
Bischof, John C.
[1
,2
,4
]
机构:
[1] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA
[3] CytImmune Sci Inc, Rockville, MD USA
[4] Univ Minnesota, Sch Med, Dept Urol Surg, Minneapolis, MN 55455 USA
来源:
关键词:
biodistribution;
cryosurgery;
CYT-6091;
gold nanoparticle;
TNF;
TUMOR-NECROSIS-FACTOR;
COLLOIDAL GOLD;
THERMAL THERAPY;
PARTICLE-SIZE;
CANCER;
DELIVERY;
NANOTECHNOLOGY;
RAT;
D O I:
10.2217/NNM.09.21
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
Aim: In this study, we describe the biodistribution of CYT-6091, a colloidal gold (Au)-based nanomedicine that targets the delivery of TNF-alpha to solid tumors. Materials & methods: A single intravenous injection of CYT-6091 coated with 5 mu g TNF-alpha was given to human prostate tumor-bearing or naive (without tumor) nude mice. Tissues were harvested and analyzed at specific time points for Au nanoparticles by atomic emission spectroscopy and TNF-alpha by ELISA. Results: The two constituents of CYT-6091, TNF-alpha and Au, exhibited different behavior in blood, with TNF-alpha showing a faster decay than the Au nanoparticles. Between 0 and 4 h after injection, TNF-alpha showed a preferential accumulation in the tumor. Au was observed to accumulate preferentially in the liver between 4 and 12 h, and showed some clearance over time (4 months). Conclusion: These data suggest that CYT-6091 delivers TNF-alpha preferentially to the tumor and that upon TNF-alpha degradation, the liver takes up Au, which is cleared slowly over time.
引用
收藏
页码:401 / 410
页数:10
相关论文